首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Detection of Pseudomonas aeruginosa producing metallo-beta-lactamase VIM-2 in a central hospital from Portugal.
【24h】

Detection of Pseudomonas aeruginosa producing metallo-beta-lactamase VIM-2 in a central hospital from Portugal.

机译:在葡萄牙的一家中心医院中检测到产生金属β-内酰胺酶VIM-2的铜绿假单胞菌。

获取原文
获取原文并翻译 | 示例
       

摘要

Pseudomonas aeruginosa remains one of the most important pathogens in the nosocomial setting [1]. P. aeruginosa exhibits intrinsic resistance to several antimicrobial agents. The antipseudomonal beta-lactams represent a major weapon against Pseudomonas infections, either for monotherapy or for combination therapy, for which beta-lactams almost invariably represent one of the components. Therefore, resistance to these agents constitutes a major challenge for anti-Pseudomonas chemotherapy. Several mechanisms can contribute to beta-lactam resistance in P. aeruginosa, including beta-lactamase production, outer membrane impermeability and active efflux mediated by RND-type efflux systems [1].
机译:铜绿假单胞菌仍然是医院中最重要的病原体之一[1]。铜绿假单胞菌对几种抗菌剂表现出固有的抗性。无论是单一疗法还是联合疗法,抗假单胞菌的β-内酰胺都是抵抗假单胞菌感染的主要武器,β-内酰胺几乎总是代表其中的一种成分。因此,对这些药剂的抗性构成了抗假单胞菌化学疗法的主要挑战。铜绿假单胞菌的β-内酰胺耐药性有多种机制,包括β-内酰胺酶的产生,外膜不渗透性和RND型外排系统介导的主动外排[1]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号